Loading clinical trials...
Loading clinical trials...
A Randomized, Open-Label, 4-Way Crossover, Pharmacokinetic Study to Compare CBD-NE to Epidyolex in Healthy Adult Volunteers Under Both Fed and Fasted Conditions
Conditions
Interventions
Cannabidiol (CBD) Powder
Cannabidiol 100 MG/ML [Epidiolex]
Locations
1
Canada
Nutrasource Site (Apex Trials)
Guelph, Ontario, Canada
Start Date
August 30, 2024
Primary Completion Date
November 20, 2024
Completion Date
December 16, 2024
Last Updated
December 17, 2024
NCT07310901
NCT06342713
NCT07471204
NCT07401472
NCT07231497
NCT07412353
Lead Sponsor
dsm-firmenich Switzerland AG
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions